Background/Objectives: The bolus dose of norepinephrine (NE) for the treatment of spinal anesthesia-induced maternal hypotension remains unclear. The aim of this study was to compare the efficacy and safety of two different bolus doses of NE in the treatment of spinal anesthesia-induced maternal hypotension during cesarean section (CS). Methods: This study has a prospective, randomized and double-blinded design. A total of 150 patients with ASA physical status I and II who underwent CS included the study at a tertiary-care university hospital. Patients were randomly assigned to either the 6 µg NE bolus (Group 6 µg, n = 75) or 8 µg NE bolus (Group 8 µg, n = 75) group. The primary outcome of this study was to determine the success rate of treatment using a 6 or 8 µg NE bolus in cases of maternal hypotension. Secondary outcomes included comparing fetal umbilical blood gas values and APGAR scores in neonates born to mothers who received a NE bolus before delivery, determining the incidence of NE-induced reactive bradycardia and hypertension, and comparing the groups for intraoperative nausea and vomiting. Results: The 8 µg group showed fewer hypotensive episodes (245 vs. 174 episodes, p = 0.012) and required fewer norepinephrine boluses. Additionally, the success rate of hypotension treatment was higher in the 8 µg group (61.2% vs. 78.5%, p < 0.001). There was no difference in APGAR scores between the groups of neonates born to women who received norepinephrine before delivery. However, in the group with 8 µg NE, slightly better results were obtained in blood gas samples, excluding the pH value. Nausea was more frequently observed in the 6 µg group (p = 0.046). Conclusions: We concluded that an 8 µg bolus administration of NE was more effective than a 6 µg bolus administration in treating maternal hypotension induced by spinal anesthesia, without any increase in the rate of side effects.
Background: Lumbar facet joints are a significant source of chronic low back pain (CLBP), and medial branch blocks (MBBs) are the widely accepted reference diagnostic approach for diagnosis. However, clinical response varies. This study aims to investigate whether sagittal spinopelvic alignment parameters can predict the clinical efficacy of MBB in patients with facet-mediated CLBP. Methods: In this prospective observational study, 110 patients (aged 40–80) with facet-related CLBP underwent diagnostic MBBs using a double-block protocol. Spinopelvic parameters, including pelvic incidence (PI), pelvic tilt (PT), sacral slope (SS), and lumbar lordosis (LL), were measured on standing lateral radiographs. Clinical response was defined as a ≥80% reduction in Visual Analog Scale (VAS) scores. Data were analyzed using multivariate logistic regression and Receiver Operating Characteristic (ROC) curves. Results: Responders (n = 68) were significantly younger and had a lower BMI than non-responders (n = 42) (p < 0.05). Non-responders exhibited significantly higher PI–LL mismatch (18.6° ± 7.4 vs. 3.9° ± 4.2, p < 0.001), higher PT (23.6° ± 5.1 vs. 17.4° ± 4.5, p < 0.001), and lower LL (35.8° ± 7.2 vs. 45.2° ± 6.4, p < 0.001). ROC analysis identified a PI–LL mismatch threshold of >12.5° as the strongly associated with negative short-term diagnostic response (AUC = 0.892). Multivariate analysis confirmed that PI–LL mismatch > 12.5° was a potential associated factor within the investigated model of poor response (OR: 4.25, 95% CI: 2.10–8.60, p < 0.001), while age and BMI were not significant in the adjusted model. Conclusions: Sagittal spinopelvic malalignment, specifically an increased PI–LL mismatch, is strongly associated with reduced diagnostic utility of MBB. Integrating biomechanical assessment into clinical decision-making may improve patient selection and treatment outcomes for facet-mediated pain.
About Me
Tıp doktoru , Anesteziyoloji veReanimasyon , Algoloji
Tıp doktoru , Anesteziyoloji veReanimasyon , Algoloji